Journal of Veterinary Medical Science
Online ISSN : 1347-7439
Print ISSN : 0916-7250
ISSN-L : 0916-7250

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

A pilot study investigating renal biomarkers in dogs with pulmonary hypertension: a comparison between cystatin-C, symmetric dimethylarginine, and creatinine
Zi Ping LEONG
著者情報
ジャーナル オープンアクセス 早期公開

論文ID: 25-0034

この記事には本公開記事があります。
詳細
抄録

Pulmonary hypertension (PH) can affect renal function, yet renal dysfunction in canine PH is relatively underexplored. Cystatin C (CYS-C), a useful marker for evaluating renal function in humans with PH, has not been studied in dogs. This study aimed to compare seventeen dogs with PH to a control group, evaluating the relationship between PH and renal parameters such as symmetric dimethylarginine (SDMA), creatinine, and CYS-C. The mean tricuspid regurgitation maximal velocity (TRmax) and systolic pulmonary arterial pressure (SPAP) in dogs with PH was 4.24 m/sec and 74.48 mmHg, respectively. Dogs with PH exhibited significantly higher SDMA (15.47 μg/dL vs. 10.55 μg/dL) and CYS-C (1.36 mg/L vs. 0.88 mg/L) compared to controls. SDMA showed moderate positive correlations with SPAP (r=0.682) and TRmax (r=0.662), and a negative moderate correlation with mean arterial pressure (r=–0.590). CYS-C moderately correlated with SPAP (r=0.529), TRmax (r=0.485), heart rate (r=0.506), and body weight (r=0.691). Creatinine did not vary significantly between PH group (122.21 μmol/L) and controls (93.70 μmol/L), nor did it correlate with any parameters. Multivariate analysis revealed that CYS-C was significantly influenced by PH severity, while SDMA and creatinine were not. These findings suggest that renal dysfunction is prevalent in dogs with PH. CYS-C may be a more sensitive marker for detecting early renal changes linked to PH severity, while SDMA appears to be more specific to true renal dysfunction and creatinine was the least informative biomarker.

著者関連情報
© 2025 by the Japanese Society of Veterinary Science

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
feedback
Top